Physicochemical properties and stability of two differently prepared amorphous forms of simvastatin

被引:84
作者
Graeser, Kirsten A. [1 ,2 ,3 ]
Strachan, Clare J. [4 ]
Patterson, James E. [3 ]
Gordon, Keith C.
Rades, Thomas [1 ,2 ]
机构
[1] Univ Otago, Sch Pharm, Dunedin, New Zealand
[2] Univ Otago, Dept Chem, Dunedin, New Zealand
[3] GlaxoSmithKline R&D, Harlow, Essex, England
[4] Univ Helsinki, Drug Discovery & Dev Technol Ctr, FIN-00014 Helsinki, Finland
关键词
D O I
10.1021/cg700913m
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The purpose of this work was to investigate possible differences in physicochemical properties and stability between amorphous forms of simvastatin prepared by (a) cryo-milling and (b) melting and quench-cooling. Both methods resulted in X-ray amorphous forms and HPLC analysis indicated a small percentage of chemical degradation during the preparation processes. Modulated differential scanning calorimetry (MTDSC) results showed significantly different onset temperatures of recrystallization and recrystallization enthalpies for both amorphous forms. Raman spectra of the amorphous forms showed differences in the intensities of the methylene bands for the cryo-milled and quench-cooled forms. Upon storage at 20 degrees C, the cryo-milled samples recrystallized within one day, whereas the quench-cooled samples showed no signs of recrystallization, even when stored at 40 degrees C for 3 days. Principal component analysis was carried out to further analyze any differences in the Raman spectra. The results indicate the existence of an amorphous form for the cryo-milled simvastatin that is spectrally distinguishable from the quench-cooled amorphous form. The thermodynamic parameters suggest that this form is less disordered compared to the quench-cooled form.
引用
收藏
页码:128 / 135
页数:8
相关论文
共 19 条
[1]   A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[2]   Simvastatin [J].
Cejka, J ;
Kratochvíl, B ;
Císarová, I ;
Jegorov, A .
ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 2003, 59 (08) :O428-O430
[3]   The effect of crystal morphology and mill type on milling induced crystal disorder [J].
Chikhalia, V ;
Forbes, RT ;
Storey, RA ;
Ticehurst, M .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 27 (01) :19-26
[4]   The measurement of small quantities of amorphous material - Should we be considering the rigid amorphous fraction? [J].
Craig, DQM ;
Kett, VL ;
Murphy, JR ;
Price, DM .
PHARMACEUTICAL RESEARCH, 2001, 18 (08) :1081-1082
[5]  
DESPINA L, 2003, J PHYS CHEM SOLIDS, V64, P343
[6]  
Ellison D.K., 1993, ANAL PROFILES DRUG S, P359, DOI DOI 10.1016/S0099-5428(08)60246-4
[7]  
Guillory J.K., 1999, Polymorphism in pharmaceutical solids, P183
[8]   Characteristics and significance of the amorphous state in pharmaceutical systems [J].
Hancock, BC ;
Zograf, G .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (01) :1-12
[9]   Polyamorphism: a pharmaceutical science perspective [J].
Hancock, BC ;
Shalaev, EY ;
Shamblin, SL .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2002, 54 (08) :1151-1152
[10]  
OLEARY TJ, 1993, CHOLESTEROL MEMBRANE, P175